ArticleGynecologic oncology reports2025
Fertility preservation in patients with ovarian tumours - a single centre experience.
Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: A report of the 15 years'-experience in fertility preservation in women with ovarian tumours, at the Fertility Preservation Centre of the Methods: A retrospective analysis of our centre database was made, including pre-pubertal and fertile-aged female patients diagnosed with ovarian tumours referred to a Fertility Preservation appointment from January 2009 to January 2024. Results: Twenty-one patients were referred for a fertility preservation appointment and 62 % had oocytes or ovarian tissue cryopreserved, seven of them after tumour recurrence. Six women had their oocytes cryopreserved and despite the site of the tumour, we achieved a medium oocyte yield of five oocytes in metaphase II. One patient has already used her frozen oocytes, but embryo development arrested before transfer. The youngest patient in whom ovarian tissue was frozen was a 4-months' old infant. Ovarian tissue thawing and transplantation was already done in two patients of 31 and 35 years old, but function was not restored. No live births were registered so far. Conclusion: Fertility preservation options should be offered to every woman with an ovarian tumour before oncological treatment, considering the ongoing research in this field. Further monitoring is needed to better evaluate both recurrence-risks and live births' rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.